Related references
Note: Only part of the references are listed.Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population
Tracey G. Simon et al.
ANNALS OF INTERNAL MEDICINE (2019)
Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea
Sang-Wook Yi et al.
CANCER (2018)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study
Gyuri Kim et al.
JOURNAL OF HEPATOLOGY (2018)
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding
Gary D. Friedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Meta-analysis of studies using statins as a reducer for primary liver cancer risk
Guo-Chao Zhong et al.
SCIENTIFIC REPORTS (2016)
Statins and Reduced Risk of Liver Cancer: Evidence for Confounding
Gary D. Friedman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin Use and Risk for Primary Liver Cancer in the Clinical Practice Research Datalink
Katherine A. McGlynn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Opposite Association Between Diabetes, Dyslipidemia, and Hepatocellular Carcinoma Mortality in the Middle-Aged and Elderly
Chien-Hsieh Chiang et al.
HEPATOLOGY (2014)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Goodarz Danaei et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
Jonathan R. Emberson et al.
PLOS ONE (2012)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Share Paper
